Back to Authors

Bigio, Eileen H.

https://orcid.org/0000-0002-9554-1138

A5068784480 | I111979921

Mayo Clinic

Northwestern University

Citations 20

Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States

JAMA Neurology | December 22, 2014 | Volume: 72 | Issue: 2 | Pages: 209

10.1001/jamaneurol.2014.2157 | PMID 25531812

Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease

JAMA Neurology | September 8, 2014 | Volume: 71 | Issue: 11 | Pages: 1394

10.1001/jamaneurol.2014.1491 | PMID 25199842

Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration

Neuropathology and Applied Neurobiology | April 19, 2014 | Volume: 40 | Issue: 6 | Pages: 778-782

10.1111/nan.12144 | PMID 24750115

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

Neurology | September 12, 2013 | Volume: 81 | Issue: 15 | Pages: 1332-1341

10.1212/wnl.0b013e3182a8250c | PMID 24027057

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

Neurology | May 14, 2012 | Volume: 56 | Issue: 12 | Pages: 1702-1706

10.1212/wnl.56.12.1702 | PMID 11425937

Genotype patterns atPICALM, CR1, BIN1, CLU, andAPOEgenes are associated with episodic memory

Neurology | April 27, 2012 | Volume: 78 | Issue: 19 | Pages: 1464-1471

10.1212/wnl.0b013e3182553c48 | PMID 22539578

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Alzheimer's & Dementia | January 19, 2012 | Volume: 8 | Issue: 1 | Pages: 1-13

10.1016/j.jalz.2011.10.007 | PMID 22265587

Abstract A consensus panel from the United States and Europe was convened recently to update and revise the 1997 consensus guidelines for the neuropathologic evaluation of Alzheimer's disease (AD) and other diseases of brain that are common in the elderly. The new guidelines recognize the pre‐clinical stage of AD, enhance the assessment of AD to include amyloid accumulation as well as neurofibrillary change and neuritic plaques, establish protocols for the neuropathologic assessment of Lewy body disease, vascular brain injury, hippocampal sclerosis, and TDP‐43 inclusions, and recommend standard approaches for the workup of cases and their clinico‐pathologic correlation.
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers

Neurology | December 22, 2010 | Volume: 76 | Issue: 5 | Pages: 467-474

10.1212/wnl.0b013e31820a0e3b | PMID 21178100

P3‐287: TDP‐43 A315T mutation in familial motor neuron disease

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_18 | Pages: No page available

10.1016/j.jalz.2008.05.1855

Clinicopathologic correlation in PGRN mutations

Neurology | May 24, 2007 | Volume: 69 | Issue: 11 | Pages: 1113-1121

10.1212/01.wnl.0000267701.58488.69 | PMID 17522386